The IEO European Institute of Oncology shared a post on LinkedIn:
“‘The patient must never lose hope. Never. Because hope is the engine of the sick. It is what allows him to face the treatment pathway.’
With these words, in the interview with the Corriere della Sera, our Prof. Giuseppe Curigliano, Deputy Scientific Director and Director of the IEO New Drug Development Division, recalls how, in the treatment pathway, the human dimension is as fundamental as the scientific one.
Today, technologies such as CT, PET, magnetic resonance imaging and liquid biopsy make it possible to intercept cancer at increasingly early stages, while artificial intelligence supports specialists in data analysis and in choosing the most suitable therapies, making the goal of responding to every need more concrete. Alongside these advances, prevention – healthy lifestyles, regular physical activity, targeted screening – remains a fundamental ally to protect health over time.
At IEO we put all this at the service of the person, with attention, competence and listening, because it is precisely by understanding the needs and fears of those who entrust us with their care that medicine can be truly effective.
Find out more, read the full interview.”
Other articles featuring Giuseppe Curigliano on OncoDaily.